Tempest Therapeutics Stock Price History
TPST Stock | USD 0.91 0.02 2.25% |
Below is the normalized historical share price chart for Tempest Therapeutics extending back to November 12, 2012. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Tempest Therapeutics stands at 0.91, as last reported on the 22nd of November, with the highest price reaching 0.93 and the lowest price hitting 0.87 during the day.
If you're considering investing in Tempest Stock, it is important to understand the factors that can impact its price. Tempest Therapeutics owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.11, which indicates the firm had a -0.11% return per unit of risk over the last 3 months. Tempest Therapeutics exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Tempest Therapeutics' Coefficient Of Variation of (803.57), variance of 26.04, and Risk Adjusted Performance of (0.09) to confirm the risk estimate we provide.
At this time, Tempest Therapeutics' Common Stock Total Equity is comparatively stable compared to the past year. Liabilities And Stockholders Equity is likely to gain to about 70.9 M in 2024, whereas Capital Stock is likely to drop slightly above 11.3 K in 2024. . At this time, Tempest Therapeutics' Price Book Value Ratio is comparatively stable compared to the past year. Price Earnings To Growth Ratio is likely to gain to 0.06 in 2024, whereas Price To Operating Cash Flows Ratio is likely to drop (2.60) in 2024. Tempest Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 12th of November 2012 | 200 Day MA 2.4266 | 50 Day MA 1.1623 | Beta (2.78) |
Tempest |
Sharpe Ratio = -0.1072
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | TPST |
Estimated Market Risk
5.19 actual daily | 46 54% of assets are more volatile |
Expected Return
-0.56 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.11 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Tempest Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Tempest Therapeutics by adding Tempest Therapeutics to a well-diversified portfolio.
Price Book 3.4039 | Book Value 1.214 | Enterprise Value 34.6 M | Enterprise Value Ebitda 0.3057 | Shares Float 21.7 M |
Tempest Therapeutics Stock Price History Chart
There are several ways to analyze Tempest Stock price data. The simplest method is using a basic Tempest candlestick price chart, which shows Tempest Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | September 17, 2024 | 1.51 |
Lowest Price | November 18, 2024 | 0.85 |
Tempest Therapeutics November 22, 2024 Stock Price Synopsis
Various analyses of Tempest Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Tempest Stock. It can be used to describe the percentage change in the price of Tempest Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Tempest Stock.Tempest Therapeutics Price Daily Balance Of Power | 0.33 | |
Tempest Therapeutics Accumulation Distribution | 48,012 | |
Tempest Therapeutics Price Rate Of Daily Change | 1.02 | |
Tempest Therapeutics Price Action Indicator | 0.02 |
Tempest Therapeutics November 22, 2024 Stock Price Analysis
Tempest Stock Price History Data
The price series of Tempest Therapeutics for the period between Sat, Aug 24, 2024 and Fri, Nov 22, 2024 has a statistical range of 0.66 with a coefficient of variation of 15.43. The price distribution for the period has arithmetic mean of 1.2. The median price for the last 90 days is 1.24. The company completed stock split (1:15) on 28th of June 2021. Tempest Therapeutics had dividends distributed to its stock-holders on 2018-12-10.Open | High | Low | Close | Volume | ||
11/22/2024 | 0.89 | 0.93 | 0.87 | 0.91 | 744,188 | |
11/21/2024 | 0.89 | 0.92 | 0.87 | 0.89 | 696,344 | |
11/20/2024 | 0.90 | 0.91 | 0.84 | 0.90 | 1,038,849 | |
11/19/2024 | 0.85 | 0.92 | 0.81 | 0.87 | 2,326,834 | |
11/18/2024 | 0.87 | 0.88 | 0.80 | 0.85 | 2,969,038 | |
11/15/2024 | 0.96 | 0.97 | 0.83 | 0.89 | 3,423,063 | |
11/14/2024 | 0.97 | 1.03 | 0.97 | 0.97 | 1,532,561 | |
11/13/2024 | 0.94 | 1.04 | 0.94 | 0.97 | 3,413,688 | |
11/12/2024 | 1.10 | 1.16 | 1.05 | 1.08 | 3,307,786 | |
11/11/2024 | 1.11 | 1.12 | 1.04 | 1.10 | 2,428,272 | |
11/08/2024 | 1.06 | 1.11 | 1.01 | 1.09 | 2,158,439 | |
11/07/2024 | 1.05 | 1.10 | 1.03 | 1.06 | 2,058,750 | |
11/06/2024 | 1.00 | 1.04 | 0.95 | 1.04 | 1,864,053 | |
11/05/2024 | 0.97 | 1.02 | 0.94 | 1.00 | 2,567,279 | |
11/04/2024 | 0.90 | 0.96 | 0.86 | 0.94 | 2,366,209 | |
11/01/2024 | 0.91 | 0.96 | 0.89 | 0.91 | 2,058,528 | |
10/31/2024 | 0.95 | 0.98 | 0.90 | 0.92 | 2,138,740 | |
10/30/2024 | 0.95 | 1.05 | 0.88 | 0.96 | 7,710,069 | |
10/29/2024 | 1.16 | 1.21 | 1.10 | 1.10 | 7,054,336 | |
10/28/2024 | 1.09 | 1.15 | 1.06 | 1.10 | 3,551,004 | |
10/25/2024 | 1.06 | 1.13 | 1.05 | 1.09 | 3,549,462 | |
10/24/2024 | 1.08 | 1.09 | 1.03 | 1.06 | 2,523,922 | |
10/23/2024 | 1.03 | 1.14 | 1.03 | 1.08 | 3,450,129 | |
10/22/2024 | 1.03 | 1.07 | 1.03 | 1.05 | 2,987,910 | |
10/21/2024 | 1.11 | 1.11 | 1.04 | 1.05 | 4,020,705 | |
10/18/2024 | 1.13 | 1.16 | 1.09 | 1.10 | 4,359,110 | |
10/17/2024 | 1.12 | 1.20 | 1.02 | 1.15 | 10,398,685 | |
10/16/2024 | 1.43 | 1.59 | 1.09 | 1.11 | 35,786,217 | |
10/15/2024 | 1.03 | 1.19 | 1.03 | 1.17 | 9,967,640 | |
10/14/2024 | 1.03 | 1.10 | 0.92 | 1.07 | 3,571,009 | |
10/11/2024 | 1.07 | 1.10 | 0.98 | 1.02 | 5,076,587 | |
10/10/2024 | 1.57 | 1.59 | 1.02 | 1.10 | 51,984,517 | |
10/09/2024 | 1.39 | 1.39 | 1.31 | 1.35 | 296,184 | |
10/08/2024 | 1.42 | 1.44 | 1.38 | 1.39 | 235,681 | |
10/07/2024 | 1.39 | 1.44 | 1.38 | 1.41 | 343,411 | |
10/04/2024 | 1.40 | 1.47 | 1.37 | 1.42 | 356,930 | |
10/03/2024 | 1.31 | 1.46 | 1.31 | 1.36 | 512,677 | |
10/02/2024 | 1.30 | 1.35 | 1.26 | 1.34 | 551,300 | |
10/01/2024 | 1.42 | 1.42 | 1.32 | 1.33 | 253,692 | |
09/30/2024 | 1.36 | 1.45 | 1.36 | 1.40 | 216,968 | |
09/27/2024 | 1.32 | 1.38 | 1.30 | 1.37 | 229,683 | |
09/26/2024 | 1.27 | 1.34 | 1.27 | 1.30 | 244,659 | |
09/25/2024 | 1.27 | 1.32 | 1.25 | 1.28 | 216,472 | |
09/24/2024 | 1.33 | 1.33 | 1.26 | 1.26 | 292,872 | |
09/23/2024 | 1.35 | 1.39 | 1.27 | 1.30 | 559,856 | |
09/20/2024 | 1.44 | 1.44 | 1.35 | 1.35 | 413,857 | |
09/19/2024 | 1.46 | 1.51 | 1.41 | 1.41 | 416,917 | |
09/18/2024 | 1.48 | 1.49 | 1.37 | 1.41 | 498,689 | |
09/17/2024 | 1.38 | 1.54 | 1.36 | 1.51 | 820,697 | |
09/16/2024 | 1.43 | 1.45 | 1.35 | 1.36 | 274,507 | |
09/13/2024 | 1.33 | 1.46 | 1.33 | 1.45 | 356,208 | |
09/12/2024 | 1.38 | 1.40 | 1.33 | 1.33 | 238,122 | |
09/11/2024 | 1.35 | 1.41 | 1.33 | 1.38 | 365,384 | |
09/10/2024 | 1.28 | 1.34 | 1.27 | 1.32 | 280,235 | |
09/09/2024 | 1.29 | 1.30 | 1.23 | 1.28 | 265,533 | |
09/06/2024 | 1.26 | 1.31 | 1.23 | 1.24 | 370,445 | |
09/05/2024 | 1.22 | 1.27 | 1.17 | 1.25 | 398,930 | |
09/04/2024 | 1.20 | 1.22 | 1.12 | 1.19 | 238,489 | |
09/03/2024 | 1.25 | 1.29 | 1.16 | 1.18 | 502,237 | |
08/30/2024 | 1.36 | 1.37 | 1.27 | 1.29 | 421,810 | |
08/29/2024 | 1.34 | 1.39 | 1.31 | 1.35 | 501,119 |
About Tempest Therapeutics Stock history
Tempest Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Tempest is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Tempest Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Tempest Therapeutics stock prices may prove useful in developing a viable investing in Tempest Therapeutics
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 15.4 M | 16.2 M | |
Net Loss | -25.5 M | -26.7 M |
Tempest Therapeutics Quarterly Net Working Capital |
|
Tempest Therapeutics Stock Technical Analysis
Tempest Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run ETF Categories Now
ETF CategoriesList of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |
All Next | Launch Module |
Tempest Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Tempest Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Tempest Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Tempest to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.09) | |||
Jensen Alpha | (0.75) | |||
Total Risk Alpha | (1.31) | |||
Treynor Ratio | (0.59) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Additional Tools for Tempest Stock Analysis
When running Tempest Therapeutics' price analysis, check to measure Tempest Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tempest Therapeutics is operating at the current time. Most of Tempest Therapeutics' value examination focuses on studying past and present price action to predict the probability of Tempest Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tempest Therapeutics' price. Additionally, you may evaluate how the addition of Tempest Therapeutics to your portfolios can decrease your overall portfolio volatility.